SEC Company Response from CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Mar 21, 2018
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: March 21, 2018 · CIK: 0001175680 · Accession: 0001193125-18-090802
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-223563
Letter
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
March 21,
VIA EDGAR SUBMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, NE
Washington, DC 20549
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
CytoDyn Inc.
Registration Statement on Form S-3
File No. 333-223563
Ladies and Gentlemen:
CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 9:00 a.m. (Eastern time) on Friday, March 23, 2018, or as soon thereafter as practicable.
Please provide a copy of the Commission’s order declaring the Registration Statement effective to Steven M. Skolnick of Lowenstein Sandler LLP, counsel to the Company, at (646) 414-6947, as soon as the Registration Statement has been declared effective.
Very truly yours,
CytoDyn Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 March 21, 2018 VIA EDGAR SUBMISSION United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS CytoDyn Inc. Registration Statement on Form S-3 File No. 333-223563 Ladies and Gentlemen: CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 9:00 a.m. (Eastern time) on Friday, March 23, 2018, or as soon thereafter as practicable. Please provide a copy of the Commission’s order declaring the Registration Statement effective to Steven M. Skolnick of Lowenstein Sandler LLP, counsel to the Company, at (646) 414-6947, as soon as the Registration Statement has been declared effective. Very truly yours, CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer